A share price of Alto Neuroscience Inc [ANRO] is currently trading at $19.98, up 2.72%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The ANRO shares have gain 32.06% over the last week, with a monthly amount glided 28.57%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Chardan Capital Markets started tracking the stock with Buy rating on September 29, 2025, and set its price target to $15. On October 23, 2024, downgrade downgraded it’s rating to Neutral and revised its price target to $4 on the stock. Rodman & Renshaw downgraded its rating to a Neutral. Wedbush initiated its recommendation with a Outperform and recommended $29 as its price target on September 03, 2024. In a note dated February 27, 2024, TD Cowen initiated an Outperform rating.
Alto Neuroscience Inc experienced fluctuations in its stock price throughout the past year between $1.60 and $19.97. Currently, Wall Street analysts expect the stock to reach $16 within the next 12 months. Alto Neuroscience Inc [NYSE: ANRO] shares were valued at $19.98 at the most recent close of the market. An investor can expect a potential drop of -19.92% based on the average ANRO price forecast.
Analyzing the ANRO fundamentals
Gross Profit Margin for this corporation currently stands at -0.7% with Operating Profit Margin at -178.28%, Pretax Profit Margin comes in at -164.62%, and Net Profit Margin reading is -164.62%. To continue investigating profitability, this company’s Return on Assets is posted at -0.41, Equity is -0.45 and Total Capital is -0.47. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 19.06 points at the first support level, and at 18.14 for the second support level. However, for the 1st resistance point, the stock is sitting at 20.90, and for the 2nd resistance point, it is at 21.83.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Alto Neuroscience Inc [NYSE:ANRO] is 15.42. In addition, the Quick Ratio stands at 15.42 and the Cash Ratio stands at 18.16.
